Materials • Major Chemicals
$13.99 ▼ -0.01
(-0.07%)
MKT CAP: $396.2M • VOL: 10.1K
52W L $11 52W H $19
ROARABLE / RQD
E • 34/100
PIOTROSKI
2 / 9
VHI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.08B | $2.10B | $1.92B |
| YoY Revenue Growth % | -1.3% | +9.5% | — |
| Gross Profit | $295.4M | $424.5M | — |
| Gross Margin % | 14.2% | 20.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $63.3M | $210.7M | $34.2M |
| Operating Margin % | 3.0% | 10.0% | 1.8% |
| Net Income (GAAP) | -$57.6M | $108.0M | -$9.9M |
| EBITDA (Normalized) | $100.6M | $235.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$35.5M | $44.0M | $3.9M |
| Capital Expenditures (CapEx) | $46.6M | $30.9M | — |
| Free Cash Flow (FCF) | -$82.1M | $13.1M | $3.9M |
| FCF Margin % | -4.0% | 0.6% | 0.2% |
| Return on Invested Capital (ROIC %) | 6.2% | 24.2% | — |
| Cash & Short-Term Equivalents | $214.0M | $348.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.02B | $1.04B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR VHI.